Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy

T-I Lee1, Y-H Kao, Y-C Chen

  • 1Department of General Medicine, College of Medicine, Taipei Medical University, Taiwan.

Insights

Peroxisome proliferator-activated receptors (PPARs) are crucial for managing energy and lipid balance in diabetes. This review explores their role in diabetic heart disease, inflammation, and cardiac electrical function.

Area of Science:

  • Cardiovascular Science
  • Metabolic Disease Research
  • Molecular Biology

Background:

  • Cardiovascular disease (CVD) is a major complication of diabetes mellitus (DM), characterized by chronic inflammation and impaired myocardial energy and lipid metabolism.
  • Peroxisome proliferator-activated receptors (PPARs), a nuclear receptor superfamily, are key regulators of energy and lipid homeostasis.
  • The three PPAR isoforms (α, γ, and δ) are expressed in the heart and influence myocardial metabolism, inflammation, and oxidative stress.

Purpose of the Study:

  • To review the multifaceted roles of PPARs and their agonists in the context of diabetes mellitus (DM).
  • To elucidate the impact of PPARs on diabetic cardiomyopathy, inflammation, and cardiac electrophysiology.

Main Methods:

  • Literature review focusing on the roles of PPARs and their agonists in DM-related cardiovascular complications.
  • Analysis of studies investigating PPAR expression and function in cardiac tissue under diabetic conditions.
  • Synthesis of findings related to PPARs' effects on myocardial lipid metabolism, glucose homeostasis, inflammation, oxidative stress, and cardiac electrical activity.

Main Results:

  • PPARs are integral to maintaining myocardial lipid and energy homeostasis, crucial for mitigating DM-induced cardiac dysfunction.
  • PPAR activation demonstrates potential in modulating inflammation and oxidative stress, key contributors to diabetic cardiomyopathy.
  • PPARs significantly influence cardiac electrical activity and may play a role in preventing or treating cardiac arrhythmias in diabetic patients.

Conclusions:

  • PPARs represent a promising therapeutic target for managing diabetic cardiomyopathy and associated cardiovascular risks.
  • Understanding PPAR regulation is vital for developing novel strategies to address the complex interplay between diabetes, inflammation, and heart disease.
  • Further research into PPAR agonists could lead to improved treatments for diabetic cardiovascular complications, including arrhythmias.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...